{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:49:27Z","timestamp":1790189367929,"version":"4.1.0"},"reference-count":64,"publisher":"Portland Press Ltd.","issue":"7","license":[{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7,22]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Antibiotic heteroresistance is a form of within-isolate susceptibility heterogeneity in which an apparently susceptible bacterial population contains rare subpopulations capable of growth at substantially higher antibiotic concentrations. It is commonly defined as resistant minorities occurring at frequencies \u226510\u22127 and growing at concentrations at least eight-fold above those that inhibit the dominant population, as demonstrated by population analysis profiling or related assays. This phenomenon has been described in diverse Gram-negative and Gram-positive pathogens and across multiple drug classes and is frequently characterized by instability, with resistant subpopulations expanding under treatment and contracting once drug pressure is relieved. This dynamic behavior contributes to systematic under-detection by routine antimicrobial susceptibility testing, which is optimized for population-average endpoints and may miss clinically relevant resistant tails, helping explain treatment failure despite \u2018susceptible\u2019 results. Mechanistically, heteroresistance spans a continuum from genotypic processes, including gene amplification, plasmid copy-number variation, transposition, and point mutations, to phenotypic mechanisms driven by reversible regulatory and physiological states such as transcriptional reprogramming, stochastic expression variability, and intergenerational phenotypic memory. These mechanisms can coexist and shift under antibiotic selection, supporting the view that heteroresistance may act as an evolutionary intermediate linking susceptibility and stable resistance. Recent advances in single-cell phenotyping, copy-number-aware genomics, transcriptomics, pharmacodynamic and population modeling, and machine-learning-assisted diagnostics offer new opportunities to detect and interpret susceptibility distributions. Integrating these approaches into clinical microbiology and stewardship will be essential to improve risk stratification, guide therapy, and predict resistance evolution.<\/jats:p>","DOI":"10.1042\/bsr20260035","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T07:43:20Z","timestamp":1783064600000},"update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Bacterial heteroresistance mechanisms, dynamics, and emerging diagnostic approaches"],"prefix":"10.1042","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6779-2343","authenticated-orcid":false,"given":"Sophie","family":"Brameyer","sequence":"first","affiliation":[{"name":"Faculty of Biology, Microbiology, Ludwig-Maximilians-University M\u00fcnchen, Gro\u00dfhaderner Str. 2-4, 82152 Martinsried, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"288","published-online":{"date-parts":[[2026,7,3]]},"reference":[{"key":"2026070303424999000_B1","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/s41579-019-0218-1","article-title":"Mechanisms and clinical relevance of bacterial heteroresistance","volume":"17","author":"Andersson","year":"2019","journal-title":"Nat. Rev. Microbiol."},{"key":"2026070303424999000_B2","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/s41564-018-0342-0","article-title":"The high prevalence of antibiotic heteroresistance in pathogenic bacteria is mainly caused by gene amplification","volume":"4","author":"Nicoloff","year":"2019","journal-title":"Nat. Microbiol."},{"key":"2026070303424999000_B3","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/s42003-021-02052-x","article-title":"The highly dynamic nature of bacterial heteroresistance impairs its clinical detection","volume":"4","author":"Pereira","year":"2021","journal-title":"Commun. Biol."},{"key":"2026070303424999000_B4","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.cmi.2022.10.018","article-title":"Antibiotic heteroresistance in ESKAPE pathogens, from bench to bedside","volume":"29","author":"Roch","year":"2023","journal-title":"Clin. Microbiol. Infect."},{"key":"2026070303424999000_B5","doi-asserted-by":"publisher","first-page":"e312","DOI":"10.1016\/S2666-5247(23)00374-9","article-title":"Heteroresistance is a cause of discrepant antibiotic susceptibility testing results","volume":"5","author":"Ozturk","year":"2024","journal-title":"Lancet Microbe"},{"key":"2026070303424999000_B6","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.molcel.2019.09.028","article-title":"Bacterial heterogeneity and antibiotic survival: understanding and combatting persistence and heteroresistance","volume":"76","author":"Dewachter","year":"2019","journal-title":"Mol. Cell"},{"key":"2026070303424999000_B7","doi-asserted-by":"publisher","first-page":"3981","DOI":"10.1038\/s41467-024-48233-0","article-title":"Three concurrent mechanisms generate gene copy number variation and transient antibiotic heteroresistance","volume":"15","author":"Nicoloff","year":"2024","journal-title":"Nat. Commun."},{"key":"2026070303424999000_B8","doi-asserted-by":"publisher","first-page":"1563316","DOI":"10.3389\/fcimb.2025.1563316","article-title":"Heterogeneous subpopulations of Escherichia coli strains acquire adaptive resistance to imipenem treatment through rapid transcriptional regulation","volume":"15","author":"Luo","year":"2025","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"2026070303424999000_B9","doi-asserted-by":"publisher","first-page":"e3002457","DOI":"10.1371\/journal.pbio.3002457","article-title":"High prevalence of heteroresistance in Staphylococcus aureus caused by a multitude of mutations in core genes","volume":"22","author":"Heidarian","year":"2024","journal-title":"PLoS Biol."},{"key":"2026070303424999000_B10","doi-asserted-by":"publisher","first-page":"4655","DOI":"10.1038\/s41467-025-59807-x","article-title":"Lineage-dependent variations in single-cell antibiotic susceptibility reveal the selective inheritance of phenotypic resistance in bacteria","volume":"16","author":"Stine","year":"2025","journal-title":"Nat. Commun."},{"key":"2026070303424999000_B11","doi-asserted-by":"publisher","first-page":"16053","DOI":"10.1038\/nmicrobiol.2016.53","article-title":"Antibiotic failure mediated by a resistant subpopulation in Enterobacter cloacae","volume":"1","author":"Band","year":"2016","journal-title":"Nat. Microbiol."},{"key":"2026070303424999000_B12","doi-asserted-by":"publisher","first-page":"e02448","DOI":"10.1128\/mBio.02448-17","article-title":"Carbapenem-resistant Klebsiella pneumoniae exhibiting clinically undetected colistin heteroresistance leads to treatment failure in a murine model of infection","volume":"9","author":"Band","year":"2018","journal-title":"mBio"},{"key":"2026070303424999000_B13","doi-asserted-by":"publisher","first-page":"e3001346","DOI":"10.1371\/journal.pbio.3001346","article-title":"Heteroresistance to beta-lactam antibiotics may often be a stage in the progression to antibiotic resistance","volume":"19","author":"Band","year":"2021","journal-title":"PLoS Biol."},{"key":"2026070303424999000_B14","doi-asserted-by":"publisher","first-page":"e00793","DOI":"10.1128\/aac.00793-22","article-title":"Quantitative pharmacodynamic characterization of resistance versus heteroresistance of colistin E. coli using a semimechanistic modeling of killing curves","volume":"66","author":"Mead","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"key":"2026070303424999000_B15","doi-asserted-by":"publisher","first-page":"e2318600121","DOI":"10.1073\/pnas.2318600121","article-title":"Theoretical considerations and empirical predictions of the pharmaco- and population dynamics of heteroresistance","volume":"121","author":"Levin","year":"2024","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2026070303424999000_B16","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1128\/CMR.00058-14","article-title":"Antimicrobial heteroresistance: an emerging field in need of clarity","volume":"28","author":"El-Halfawy","year":"2015","journal-title":"Clin. Microbiol. Rev."},{"key":"2026070303424999000_B17","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1007\/s00203-024-04173-3","article-title":"Phenotypic heterogeneity in bacteria: the rise of antibiotic persistence, clinical implications, and therapeutic opportunities","volume":"206","author":"Pani","year":"2024","journal-title":"Arch. Microbiol."},{"key":"2026070303424999000_B18","doi-asserted-by":"publisher","first-page":"5721","DOI":"10.1038\/s41467-025-60828-9","article-title":"Copy number flexibility facilitates heteroresistance to increasing antibiotic pressure and threatens the beta-lactam pipeline","volume":"16","author":"Choby","year":"2025","journal-title":"Nat. Commun."},{"key":"2026070303424999000_B19","doi-asserted-by":"publisher","first-page":"dlae057","DOI":"10.1093\/jacamr\/dlae057","article-title":"Heteroresistance to piperacillin\/tazobactam Klebsiella pneumoniae mediated by increased copy number of multiple \u03b2-lactamase genes","volume":"6","author":"Babiker","year":"2024","journal-title":"JAC-Antimicrob. Resist."},{"key":"2026070303424999000_B20","doi-asserted-by":"publisher","first-page":"101038","DOI":"10.1016\/j.drup.2023.101038","article-title":"Dynamic within-host cefiderocol heteroresistance caused by blaSHV-12 amplification in pandrug-resistant and hypervirulent Klebsiella pneumoniae sequence type 11","volume":"73","author":"Liu","year":"2024","journal-title":"Drug Resist. Updat."},{"key":"2026070303424999000_B21","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1038\/s41467-024-45045-0","article-title":"Plasmid-mediated phenotypic noise leads to transient antibiotic resistance in bacteria","volume":"15","author":"Hernandez-Beltran","year":"2024","journal-title":"Nat. Commun."},{"key":"2026070303424999000_B22","doi-asserted-by":"publisher","first-page":"002048","DOI":"10.1099\/jmm.0.002048","article-title":"Dissecting rifampicin heteroresistance Mycobacterium tuberculosis: integrating whole-genome sequencing with phenotypic and clonal validation","volume":"74","author":"Vallejos-Sanchez","year":"2025","journal-title":"J. Me\u0301d. Microbiol."},{"key":"2026070303424999000_B23","doi-asserted-by":"publisher","first-page":"e01885","DOI":"10.1128\/JCM.01885-20","article-title":"Low-level rifampin resistance and rpoB mutations Mycobacterium tuberculosis: an analysis of whole-genome sequencing and drug susceptibility test data in New York","volume":"59","author":"Shea","year":"2021","journal-title":"J. Clin. Microbiol."},{"key":"2026070303424999000_B24","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1128\/JCM.05793-11","article-title":"Subpopulation analysis of heteroresistance to fluoroquinolone Mycobacterium tuberculosis isolates from Beijing, China","volume":"50","author":"Zhang","year":"2012","journal-title":"J. Clin. Microbiol."},{"key":"2026070303424999000_B25","doi-asserted-by":"publisher","first-page":"3270","DOI":"10.1128\/AAC.02066-13","article-title":"High proportion of heteroresistance gyrA and gyrB fluoroquinolone-resistant Mycobacterium tuberculosis clinical isolates","volume":"58","author":"Eilertson","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"2026070303424999000_B26","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.3390\/jcm8091444","article-title":"Colistin heteroresistance Klebsiella pneumoniae isolates and diverse mutations of PmrAB and PhoPQ in resistant subpopulations","volume":"8","author":"Cheong","year":"2019","journal-title":"J. Clin. Med."},{"key":"2026070303424999000_B27","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1128\/AAC.05055-14","article-title":"Heteroresistance to colistin Klebsiella pneumoniae associated with alterations in the PhoPQ regulatory system","volume":"59","author":"Jayol","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"2026070303424999000_B28","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.3390\/diagnostics11071165","article-title":"A molecular perspective on colistin and Klebsiella pneumoniae: mode of action, resistance genetics, and phenotypic susceptibility","volume":"11","author":"Elias","year":"2021","journal-title":"Diagnostics"},{"key":"2026070303424999000_B29","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.meegid.2013.03.047","article-title":"The evolution of vancomycin intermediate Staphylococcus aureus (VISA) and heterogenous-VISA","volume":"21","author":"Howden","year":"2014","journal-title":"Infect. Genet. Evol."},{"key":"2026070303424999000_B30","doi-asserted-by":"publisher","first-page":"5843","DOI":"10.1128\/AAC.00425-13","article-title":"Comprehensive identification of mutations responsible for heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA)-to-VISA conversion in laboratory-generated VISA strains derived from hVISA clinical strain Mu3","volume":"57","author":"Matsuo","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"2026070303424999000_B31","doi-asserted-by":"publisher","first-page":"e70007","DOI":"10.1002\/mef2.70007","article-title":"Vancomycin-intermediate Staphylococcus aureus employs CcpA-GlmS metabolism regulatory cascade to resist vancomycin","volume":"3","author":"Peng","year":"2024","journal-title":"Med. Comm. Futur. Med."},{"key":"2026070303424999000_B32","doi-asserted-by":"publisher","first-page":"e00433","DOI":"10.1128\/AAC.00433-18","article-title":"The inoculum effect in the era of multidrug resistance: minor differences in inoculum have dramatic effect on mic determination","volume":"62","author":"Smith","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"2026070303424999000_B33","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1093\/jac\/dkaa221","article-title":"Detection of heterogeneous vancomycin intermediate resistance in MRSA isolates from Latin America","volume":"75","author":"Castro","year":"2020","journal-title":"J. Antimicrob. Chemother."},{"key":"2026070303424999000_B34","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1038\/s41467-024-46571-7","article-title":"Bacteria can compensate the fitness costs of amplified resistance genes via a bypass mechanism","volume":"15","author":"Pal","year":"2024","journal-title":"Nat. Commun."},{"key":"2026070303424999000_B35","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/nrmicro2174","article-title":"Bacterial gene amplification: implications for the evolution of antibiotic resistance","volume":"7","author":"Sandegren","year":"2009","journal-title":"Nat. Rev. Microbiol."},{"key":"2026070303424999000_B36","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/nrmicro2319","article-title":"Antibiotic resistance and its cost: is it possible to reverse resistance?","volume":"8","author":"Andersson","year":"2010","journal-title":"Nat. Rev. Microbiol."},{"key":"2026070303424999000_B37","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s44259-025-00076-5","article-title":"Epidemiology, mechanisms, and clinical impact of bacterial heteroresistance","volume":"3","author":"Xu","year":"2025","journal-title":"npj Antimicrob. Resist."},{"key":"2026070303424999000_B38","doi-asserted-by":"publisher","first-page":"3282","DOI":"10.1038\/s41598-020-60381-z","article-title":"Droplet-based digital antibiotic susceptibility screen reveals single-cell clonal heteroresistance in an isogenic bacterial population","volume":"10","author":"Scheler","year":"2020","journal-title":"Sci. Rep."},{"key":"2026070303424999000_B39","doi-asserted-by":"publisher","first-page":"9620","DOI":"10.1038\/s41467-025-64759-3","article-title":"Heterogeneity in responses to ribosome-targeting antibiotics mediated by bacterial RNA repair","volume":"16","author":"Hindley","year":"2025","journal-title":"Nat. Commun."},{"key":"2026070303424999000_B40","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1128\/AAC.38.4.724","article-title":"Mechanisms of heteroresistance in methicillin-resistant Staphylococcus aureus","volume":"38","author":"Ryffel","year":"1994","journal-title":"Antimicrob. Agents Chemother."},{"key":"2026070303424999000_B41","doi-asserted-by":"publisher","first-page":"3946","DOI":"10.1128\/JCM.39.11.3946-3951.2001","article-title":"Methicillin-resistant Staphylococcus aureus: comparison of susceptibility testing methods and analysis of mecA-positive susceptible strains","volume":"39","author":"Sakoulas","year":"2001","journal-title":"J. Clin. Microbiol."},{"key":"2026070303424999000_B42","doi-asserted-by":"publisher","first-page":"3372","DOI":"10.1128\/AAC.00242-10","article-title":"Adaptive resistance to the \u201cLast Hope\u201d antibiotics polymyxin B and colistin Pseudomonas aeruginosa mediated by the novel two-component regulatory system ParR-ParS","volume":"54","author":"Ferna\u0301ndez","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"2026070303424999000_B43","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1476-0711-12-15","article-title":"Hetero- and adaptive resistance to polymyxin B in OXA-23-producing carbapenem-resistant Acinetobacter baumannii olates","volume":"12","author":"Barin","year":"2013","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"2026070303424999000_B44","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1007\/s00284-020-02064-6","article-title":"Polymyxin B heteroresistance and adaptive resistance in multidrug- and extremely drug-resistant Acinetobacter baumannii","volume":"77","author":"Genteluci","year":"2020","journal-title":"Curr. Microbiol."},{"key":"2026070303424999000_B45","doi-asserted-by":"publisher","first-page":"RP99752","DOI":"10.7554\/eLife.99752.4","article-title":"Heterogeneous efflux pump expression underpins phenotypic resistance to antimicrobial peptides","volume":"13","author":"Lee","year":"2025","journal-title":"eLife"},{"key":"2026070303424999000_B46","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1146\/annurev-micro-041522-102707","article-title":"From petri dishes to patients to populations: scales and evolutionary mechanisms driving antibiotic resistance","volume":"78","author":"Souque","year":"2024","journal-title":"Annu. Rev. Microbiol."},{"key":"2026070303424999000_B47","doi-asserted-by":"publisher","first-page":"105618","DOI":"10.1016\/j.ebiom.2025.105618","article-title":"Machine learning detection of heteroresistance Escherichia coli","volume":"113","author":"Guliaev","year":"2025","journal-title":"eBioMedicine"},{"key":"2026070303424999000_B48","doi-asserted-by":"publisher","first-page":"e1007726","DOI":"10.1371\/journal.ppat.1007726","article-title":"Heteroresistance: a cause of unexplained antibiotic treatment failure?","volume":"15","author":"Band","year":"2019","journal-title":"PLoS Pathog."},{"key":"2026070303424999000_B49","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1093\/jac\/47.4.399","article-title":"A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin Staphylococcus aureus a UK hospital","volume":"47","author":"Wootton","year":"2001","journal-title":"J. Antimicrob. Chemother."},{"key":"2026070303424999000_B50","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1128\/JCM.01128-10","article-title":"Comparison of detection methods for heteroresistant vancomycin-intermediate Staphylococcus aureus, with the population analysis profile method as the reference method","volume":"49","author":"Satola","year":"2010","journal-title":"J. Clin. Microbiol."},{"key":"2026070303424999000_B51","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.4081\/idr.2012.e20","article-title":"Screening and detection of heterogenous vancomycin intermediate Staphylococcus aureus hospital Kuala Lumpur Malaysia, using the glycopeptide resistance detection etest and population analysis profiling","volume":"4","author":"Ramli","year":"2012","journal-title":"Infect. Dis. Rep."},{"key":"2026070303424999000_B52","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1089\/mdr.2017.0212","article-title":"Emergence of daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus clinical isolates among daptomycin-naive patients in Korea","volume":"24","author":"Nam","year":"2018","journal-title":"Microb. Drug Resist."},{"key":"2026070303424999000_B53","doi-asserted-by":"publisher","first-page":"194","DOI":"10.4103\/ijmr.IJMR_1976_17","article-title":"Detection of heterogeneous vancomycin-intermediate Staphylococcus aureus: a preliminary report from south India","volume":"150","author":"Amberpet","year":"2019","journal-title":"Indian J. Me\u0301d. Res."},{"key":"2026070303424999000_B54","doi-asserted-by":"publisher","first-page":"12689","DOI":"10.1038\/s41598-020-69058-z","article-title":"Global prevalence and distribution of vancomycin resistant, vancomycin intermediate and heterogeneously vancomycin intermediate Staphylococcus aureus clinical isolates: a systematic review and meta-analysis","volume":"10","author":"Shariati","year":"2020","journal-title":"Sci. Rep."},{"key":"2026070303424999000_B55","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.snb.2018.05.047","article-title":"Phenotyping antibiotic resistance with single-cell resolution for the detection of heteroresistance","volume":"270","author":"Lyu","year":"2018","journal-title":"Sens. Actuators B: Chem."},{"key":"2026070303424999000_B56","doi-asserted-by":"publisher","first-page":"109278","DOI":"10.1016\/j.mbs.2024.109278","article-title":"A birth\u2013death model to understand bacterial antimicrobial heteroresistance from time-kill curves","volume":"376","author":"Mart\u00ednez-L\u00f3pez","year":"2024","journal-title":"Math. Biosci."},{"key":"2026070303424999000_B57","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1086\/511642","article-title":"Mutant selection window hypothesis updated","volume":"44","author":"Drlica","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"2026070303424999000_B58","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/s41598-023-27723-z","article-title":"Genotypic resistance determined by whole genome sequencing versus phenotypic resistance in 234 Escherichia coli olates","volume":"13","author":"Vanstokstraeten","year":"2023","journal-title":"Sci. Rep."},{"key":"2026070303424999000_B59","doi-asserted-by":"publisher","first-page":"e2100409","DOI":"10.1002\/pmic.202100409","article-title":"Proteomics in antibiotic resistance and tolerance research: Mapping the resistome and the tolerome of bacterial pathogens","volume":"22","author":"Sulaiman","year":"2022","journal-title":"Proteomics"},{"key":"2026070303424999000_B60","doi-asserted-by":"publisher","first-page":"e01186","DOI":"10.1128\/jcm.01186-25","article-title":"Prediction of antimicrobial resistance from MALDI-TOF mass spectra using machine learning: a validation study","volume":"63","author":"Wiesmann","year":"2025","journal-title":"J. Clin. Microbiol."},{"key":"2026070303424999000_B61","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.1128\/AAC.01016-08","article-title":"Genetic analysis of colistin resistance Salmonella enterica Serovar Typhimurium","volume":"53","author":"Sun","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"2026070303424999000_B62","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1111\/mmi.13459","article-title":"Unstable tandem gene amplification generates heteroresistance (variation in resistance within a population) to colistin Salmonella enterica","volume":"102","author":"Hjort","year":"2016","journal-title":"Mol. Microbiol."},{"key":"2026070303424999000_B63","doi-asserted-by":"publisher","first-page":"7936","DOI":"10.1038\/s41467-024-52166-z","article-title":"The evolution of heteroresistance via small colony variants Escherichia coli following long term exposure to bacteriostatic antibiotics","volume":"15","author":"Gil-Gil","year":"2024","journal-title":"Nat. Commun."},{"key":"2026070303424999000_B64","doi-asserted-by":"publisher","first-page":"e1013456","DOI":"10.1371\/journal.ppat.1013456","article-title":"Antifungal persistence: clinical relevance and mechanisms","volume":"21","author":"Wang","year":"2025","journal-title":"PLoS Pathog."}],"container-title":["Bioscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/bioscirep\/article-pdf\/doi\/10.1042\/BSR20260035\/990004\/bsr-2026-0035c.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/bioscirep\/article-pdf\/doi\/10.1042\/BSR20260035\/990004\/bsr-2026-0035c.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T07:43:21Z","timestamp":1783064601000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/bioscirep\/article\/46\/7\/BSR20260035\/237800\/Bacterial-heteroresistance-mechanisms-dynamics-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":64,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7,22]]}},"URL":"https:\/\/doi.org\/10.1042\/bsr20260035","relation":{},"ISSN":["0144-8463","1573-4935"],"issn-type":[{"value":"0144-8463","type":"print"},{"value":"1573-4935","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,7]]},"published":{"date-parts":[[2026,7]]},"article-number":"BSR20260035"}}